Events:

MedTech IGNITE:

What’s it Worth?

Pricing strategies for innovative medical devices

March 15, 2012, 8:30am-10:30am

RSVP: stamp@massmedic.com

Gateway Park, WPI, Lobby Floor
60 Prescott St, Worcester, MA

MassMEDIC’s MedTech IGNITE program will host a morning session on the practical perspective of pricing new medical technologies in the current and future healthcare marketplace.  Coffee and networking from 8:30-9am followed by a discussion from 9-10:30am.

Establishing the right price point for a new medical device is tricky business.  Aim too low and you risk undervaluing your invention and leaving money on the table.  Aim too high and you may niche your product into a tiny market.  The only certainty is that entrepreneurs must answer the pricing question far sooner than most expect as price is on the top of the mind for investors and strategic partners alike.

Seasoned marketing strategist, Amy Siegel, will lead the group through an interactive session on the process of determining pricing for medical devices from implantables to capital equipment.  Industry experts, Jeff Arnold and David Freeman will lead the group through informative “real-life” pricing stories, illustrating traditional and non-traditional approaches.

Speakers:

Amy Siegel, is currently a founder of S2N Health, where she brings over 15 years experience advising emerging medical companies on market strategies.  Amy previously held VP of strategic marketing positions at Seventh Sense Biosystems and Aspect Medical Systems.

Jeff Arnold is currently the president of Arnold Strategies LLC and is a serial entrepreneur, having raised over $140M of capital.  Jeff previously served as CEO of several life science firms including CardioFocus, Cambridge Heart, Inc., and Accelrys.

David Freeman is the executive in residence at the Institute for Pediatric Innovation as well as the president of Freeman & Associates, where he brings 20+ years of experience in strategy, marketing and branding.  David previously served as general manager and chief marketing officer at GE Healthcare and VP of marketing at both BD Biosciences and Philips Healthcare.

About IGNITE:

The Mission of MassMEDIC’s MedTech IGNITE is to provide a focal point for entrepreneurs in early stage New England medical device startups where they can seek guidance to foster success.  Mentoring support, educational seminars, and outreach updates are all part of the complimentary programs supported through IGNITE.

For questions, please contact Andrea Stamp, Director of MedTech IGNITE: stamp@massmedic.com.  

 WPI Venture Forum  

As winter moves behind us and summer beckons on the horizon it’s time to shake off the cold and spring into networking mode.  The Worcester Polytechnic Venture Forum (WPI) Venture Forum and the Massachusetts Biomedical Initiatives (MBI) will be holding our first networking event of 2012 highlighting all that is life science.  During the course of the evening attendees will have the opportunity to connect with and learn about some of the amazing science taking place at Gateway Park through short presentations by researchers at the park.  Attendees will also have an opportunity to tour of the facility and learn firsthand about the life science resources available in our own backyard.

Please join us for an amazing evening of science, innovation, and networking. Event registration is free and required with event sign-in beginning at 5:00 PM at Gateway Park. Presentation and facilities tours will follow from 5:45 PM on and be ongoing throughout the evening. Light food and refreshments will be provided.

Networking reception brought to you by the WPI Venture Forum in partnership with and sponsored by Gateway Park and the MBI – Life Science Innovation Center. Special thanks to our event co-sponsor Mirick O’Connell attorneys at law.

Bio-IT World Conference & Expo
April 24-26, 2012 | World Trade Center | Boston, MA
www.bio-itworldexpo.com

Join us for the 10th anniversary celebration of the Bio-IT World Conference & Expo. The 2012 Expo plans to unite 2,000+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30+ countries. The Expo provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.

Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. Marking our 10th anniversary, the 2012 program will feature compelling talks from industry and academia on new trends in data generation, knowledge management, and information technology in life sciences and drug development. Bio-IT World Conference & Expo continues to expand with the addition of three new Tracks: Molecular Diagnostics Informatics, Open Source Solutions, and Cancer Informatics.

Spanning three days, the meeting includes 12 parallel conference tracks and 16 pre-conference workshops.

Three visionary keynote speakers will headline the 10th anniversary conference. The keynoters will be Eric D. Perakslis, Ph.D., the newly appointed CIO and Chief Scientist of Informatics, U.S. Food and Drug Administration; Martin Leach, Ph.D., CIO, Broad Institute of MIT and Harvard; and Jill P. Mesirov, Ph.D., Associate Director and Chief Informatics Officer; Director, Computational Biology and Bioinformatics, Broad Institute of MIT and Harvard.

In addition, the conference will feature a plenary panel discussion on advances in cancer diagnostics, informatics and therapeutics, in which a distinguished group of some of the most innovative and renowned cancer researchers will discuss the current state of cancer research, diagnostics, genome analysis and clinical trials. Panelists include Julian Adams (Infinity Pharmaceuticals), Jose Baselga (Massachusetts General Hospital), Sir John Burn (Newcastle University, UK), and John Quackenbush (Dana-Farber Cancer Institute).

For full program details and to register, visit www.bio-itworldexpo.com.

*Announcing New Service Program Offerings to MBI Tenant and Affiliate Companies* Providing Advisory Services for Life Science & Technology Related Businesses in partnership with the Massachusetts Small Business Development Center (MSBDC):

• Assist in the development of solid business models and in the refinement of related business plans
• Assist in the formation and development of financial models and associated projections
• Help ventures secure the capital they need across a range of options including venture capital, bank financing, SBIRs, and other state and federal programs.
• Determination of short and long term capital requirements
• Selection of source-of-capital targets (firms, individuals, agencies, etc.)
• Refinement of pitches directed to sources of capital
• Arrange contact with valuable sources of advice, counsel and support including lawyers, accountants, bankers, and others. • Assist in the utilization of solid general business practices including accounting systems, HR  practices, and partner/vendor management
• Help ventures move from science to commercialization – to understand the ways in which ventures’ intellectual property, unique advantages, and differentiation can be successfully brought to market
• Collaborate on the development and delivery of educational seminars to serve ventures’ specific needs

For more information, please contact:

Peter D. Marton, Senior Business Advisor / Technology Specialist MA
Small Business Development Center Network (MSBDC)
Central Regional Office – Clark University
Email: pemarton@clarku.edu
Mailing Address: 950 Main Street, Worcester, MA 01610-1477
Physical Address: 125 Woodland Street, Worcester, MA 01610
Phone: (508) 793-7615    Fax: (508) 793-8890
www.clarku.edu/offices/sbdc

Kevin O’Sullivan, President & CEO
Massachusetts Biomedical Initiatives (MBI)
Gateway Park, 60 Prescott Street, Worcester, MA 01605
Email: kosullivan@massbiomed.org
Phone: 508-797-4200 ext. 100
www.massbiomed.org